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Loss-of-Function Analysis of EphA Receptors in
Retinotectal Mapping
David A. Feldheim,1* Masaru Nakamoto,1* Miriam Osterfield,1 Nicholas W. Gale,2 Thomas M. DeChiara,2
Rajat Rohatgi,1 George D. Yancopoulos,2 and John G. Flanagan1
1Department of Cell Biology and Program in Neuroscience, Harvard Medical School, Boston, Massachusetts 02115, and 2Regeneron Pharmaceuticals, Inc.,
Tarrytown, New York 10591

EphA tyrosine kinases are thought to act as topographically specific receptors in the well-characterized projection map from the retina to
the tectum. Here, we describe a loss-of-function analysis of EphA receptors in retinotectal mapping. Expressing patches of a cytoplasmically truncated EphA3 receptor in chick retina caused temporal axons to have reduced responsiveness to posterior tectal repellent activity
in vitro and to shift more posteriorly within the map in vivo. A gene disruption of mouse EphA5, replacing the intracellular domain with
␤-galactosidase, reduced in vitro responsiveness of temporal axons to posterior target membranes. It also caused map abnormalities in
vivo, with temporal axons shifted posteriorly and nasal axons anteriorly, but with the entire target still filled by retinal axons. The anterior
shift of nasal axons was not accompanied by increased responsiveness to tectal repellent activity, in contrast to the comparable anterior
shift in ephrin-A knock-outs, helping to resolve a previous ambiguity in interpreting the ephrin gene knock-outs. The results show the
functional requirement for endogenous EphA receptors in retinotectal mapping, show that the receptor intracellular domain is required
for a forward signaling response to topographic cues, and provide new evidence for a role of axon competition in topographic mapping.
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Introduction
Most sensory input to the brain is mapped topographically, with
nearest neighbor relationships of the projecting neurons maintained in their connections within target areas. In this manner,
the spatial information of sensory input can be preserved as it is
transferred from one area of the nervous system to another. For
example, retinal ganglion cell (RGC) axons project topographically to retinal targets in the brain, allowing visual images to be
transferred in a spatially intact form.
In recent years, the molecular mechanisms for topographic
mapping have begun to emerge (Drescher et al., 1997; Flanagan
and Vanderhaeghen, 1998; O’Leary and Wilkinson, 1999;
Wilkinson, 2000). As proposed initially by Sperry (1963), molecules expressed in gradients across the projecting and target fields
are believed to give a unique positional identity to each location,
with axons mapping to their correct location by matching up
these positional values. In the well-characterized visual projection from the retina to the tectum, or to its mammalian equivalent, the superior colliculus (SC), EphA receptors and ephrin-A
ligands are expressed in gradients along the anterior–posterior
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(A-P) axis of both the retina and the tectum. In the RGC layer of
the retina, EphA5 and EphA6 (mouse) or EphA3 (chick) are expressed in a temporal⬎nasal gradient, whereas ephrin-A2,
ephrin-A5, and ephrin-A6 are expressed in the opposite,
nasal⬎temporal gradient (Cheng et al., 1995; Feldheim et al.,
1998, 2000; Hornberger et al., 1999; Menzel et al., 2001). In the
SC/tectum, ephrin-A2 and ephrin-A5 are expressed in
posterior⬎anterior gradients (Cheng et al., 1995; Drescher et al.,
1995; Donoghue et al., 1996; Flenniken et al., 1996; Zhang et al.,
1996; Frisén et al., 1998), whereas EphA3, EphA4, EphA5, EphA7,
and EphA8 have all been reported to be expressed in an
anterior⬎posterior gradient (Ciossek et al., 1995; Flenniken et
al., 1996; Park et al., 1997; Connor et al., 1998). The identification
of these candidate-mapping labels allows the chemoaffinity hypothesis to be functionally characterized at the molecular level.
Gain-of-function studies show that ephrin-A2 and ephrin-A5 are
sufficient to repel chick or mouse retinal axons with a topographically specific preference for temporal retinal axons in vivo (Nakamoto et al., 1996) and in vitro (Nakamoto et al., 1996; Monschau et al., 1997; Feldheim et al., 2000), showing that they have
properties expected of topographically specific guidance factors
in the target. In addition, ectopic expression of ephrin-A2 or
ephrin-A5 in nasal retina appears to mask or downregulate EphA
receptor function and, therefore, may also be important in the
retina for map formation (Hornberger et al., 1999; Feldheim et
al., 2000).
In loss-of-function studies of ephrin-A2 or ephrin-A5, when
either gene is disrupted, moderate map disturbances are seen,
demonstrating both overlapping and distinct functions for these
two ephrins in retinotectal mapping (Frisén et al., 1998; Feldheim
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et al., 2000). After double knock-out of both these ephrins, topographic order along the anteroposterior axis is more severely disrupted in vivo, and SC-derived repellent activity was undetectable
by the in vitro stripe assay (Feldheim et al., 2000). A notable
feature of the ephrin-A mutants is that although temporal axons
shift posteriorly in the target, as expected from removal of targetbased repellents, nasal axons tend to shift in the opposite direction, anteriorly. Two models have previously been proposed to
account for this anterior shift. One is based on receptor masking
by ephrins in nasal retina and proposes that the anterior shift may
be attributable to increased sensitivity of nasal axons to remaining repellents in the target (Hornberger et al., 1999; McLaughlin
and O’Leary, 1999; Feldheim et al., 2000; Wilkinson, 2000). Consistent with this model, nasal axons from ephrin mutants do have
greatly increased in vitro sensitivity to posterior SC membranes
(Feldheim et al., 2000). An alternative model is based on axon–
axon competition, proposing that the anterior shift by nasal axons may be explained by competition with other retinal axons
that terminate in the posterior tectum when repellent ephrins are
removed (Feldheim et al., 2000). This second explanation for the
mutant phenotype is consistent with a model for topographic
mapping that would rely on graded topographically specific labels, in combination with axon–axon competition for space in
the target (Fraser and Hunt, 1980; Goodhill and Richards, 1999;
Brown et al., 2000; Feldheim et al., 2000; Goodhill, 2000).
Although A ephrins have been studied the most extensively in
mapping, other molecules are also likely to have important roles.
RGM1 has recently been cloned as a molecule with topographically specific repellent activity in vitro and is expressed in an A-P
gradient in chick tectum (Monnier et al., 2002). In addition,
members of the B ephrin family and their receptors have been
shown to be important for mapping of retinal axons along the
dorsal–ventral axis (Hindges et al., 2002; Mann et al., 2002). It is
also worth noting that, in addition to a forward signal through
the Eph receptors, ephrins have the potential to act bidirectionally, with a reverse signal transduced through the ligands. Reverse
signaling has been characterized extensively for the transmembrane B ephrins (Henkemeyer et al., 1996; Holland et al., 1996;
Bruckner et al., 1997; Mellitzer et al., 1999, 2000; Birgbauer et al.,
2000; Lu et al., 2001) and also appears to occur in the glycosyl
phosphatidylinositol lipid-anchored A ephrins (Davy et al., 1999;
Davy and Robbins, 2000; Hattori et al., 2000; Knoll et al., 2001),
and it has been proposed to play a role in neuromuscular and
olfactory map development (Feng et al., 2000; Knoll et al., 2001;
Cutforth et al., 2003).
Here, we describe a loss-of-function analysis of EphA receptors in retinal axon mapping. This was done by using both a
truncated receptor approach in chick and by gene targeting in
mouse. The results were analyzed by testing both retinal axon
guidance in vitro and axon mapping in vivo. Retinas from EphA5
mutant mice, or chick retinas retrovirally transduced with a cytoplasmically truncated EphA3 receptor, showed reduced responsiveness to posteriorly derived repellent activity in vitro. In
chick, ectopic expression of patches of truncated EphA3 in the
retina caused abnormally posterior mapping of temporal axons.
In mice with a targeted mutation in EphA5, both temporal and
nasal axons mapped to incorrect locations, with temporal axons
terminating in abnormally posterior regions and nasal axons in
abnormally anterior regions, although the entire target area was
still filled by incoming axons. Taken together, these studies show
that endogenous EphA receptors are required for normal mapping, indicate that forward signaling requires the intracellular
domain of the receptor for a normal response of retinal axons to
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topographic cues, support a repellent signaling function for
EphA receptors, and provide new support for a role of competition in topographic mapping.

Materials and Methods
Expression pattern analysis and in vitro stripe assay. Hybridization probes
for mouse EphA5 (Feldheim et al., 1998) and EphA6 (Maisonpierre et al.,
1993) have been described. In situ hybridization was performed as described (Feldheim et al., 1998). Affinity probe in situ using EphA3-AP,
EphA4-AP, EphA5-AP, and ephrin-A5-AP fusion proteins was also as
described previously (Feldheim et al., 1998). Fixed cryostat sections were
stained for ␤-galactosidase expression as described by Henkemeyer et al.
(1996).
The membrane stripe assay (Walter et al., 1987a) was performed as
described previously for chick (Nakamoto et al., 1996) and mouse (Feldheim et al., 1998).
Axon tracing in EphA5 gene-targeted mice. For tracing in mice, the
eyelid was cut open to expose the eye, and 0.1–1 ml l of 10% DiI in
dimethyl formamide was injected into at the temporal or nasal extreme
of the retina with a fine glass micropipette using a Picospritzer II (General
Valve, Fairfield, NJ). One to two days later, at postnatal days (P) 12–20,
mice were analyzed blind to genotype, and a piece of tail was taken for
later genotyping. The age distributions of the wild-type and mutant
groups were similar. Grouping mutant mice by age, mapping abnormalities were seen in 27 of 52 mice at P12–P14 and 10 of 19 mice at P15–P20
( p ⫽ 0.97; Mann–Whitney U test). After fixation by cardiac perfusion
with 4% paraformaldehyde in PBS, midbrains were photographed with
fluorescence optics as whole mounts and then as 200 m vibratome
sections. Axon arborizations were confirmed by their appearance at high
magnification on whole mounts and sections. The SC boundaries were
identified by their characteristic shape and location under visible light or
by autofluorescence. All injected retinas were photographed as flat
mounts. Because there is no prominent optic fissure in mice, orientation
was determined according to the initial injection site. There was no obvious difference in the size, location, or appearance of the labeling sites,
or in the size of the retinas, that could account for the differences in the
mutant projections. Whole-eye fills with fluoresceinated cholera toxin
were performed as described (Feldheim et al., 2000).
The 5⬘ and 3⬘ fragments used in construction of the targeting vector
were isolated from a 129SV mouse genomic library in the lambda FixII
vector (Stratagene, La Jolla, CA) and cloned into the vector pKOVpLacZ,
which comprises the LacZ gene, followed by the phosphoglycerate kinase
promoter-driven neomycin resistance gene (PGK-Neo) for gene targeting in embryonic stem cells as described (DeChiara et al., 1995). Genotyping of EphA5 lacZ mice was done by PCR of genomic DNA obtained
from tails using primer GCCCGTTATGAAAGTGCATCTTTTCC immediately downstream of the fusion point in exon 8 of EphA5, the first
exon after the transmembrane domain, and primer ACTGGCATGGAAATTGGCTCTGG in intron 7 upstream of the fusion point, to detect
the wild-type gene and the neo primer GCAACTGTTGGGAAGGGCGATC. The wild-type allele yields a 200 bp product, and the mutant allele
a 300 bp product.
Retroviral constructs and axon tracing in chick. RCAS-EphA3⌬C has
been described (Nishida et al., 2002). Titers of the retrovirus stocks used
in the present studies were 1–5 ⫻ 10 8 ml ⫺1 for RCAS-EphA3⌬C. For
axon tracing experiments, retroviral stock with dye tracer was injected
into the right optic vesicle of embryonic day (E) 2 [Hamburger and
Hamilton (HH) stages 10 –12] chicken embryos in windowed eggs. Retinal axons were anterogradely labeled with DiI (Molecular Probes, Eugene, OR) on E16, and labeled axons were analyzed on E18 (HH stages
40 – 42), as described previously (Nakamoto et al., 1996).

Results

Mapping in mice with targeted mutation in EphA5 receptor
To test whether EphA5 is required for proper retinocollicular
development, we examined mice with a targeted gene disruption.
The targeted allele, EphA5lacZ, is designed to encode a fusion protein consisting of the extracellular, transmembrane, and jux-
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tamembrane domains of EphA5 linked to ␤-galactosidase. This
EphA5-␤-galactosidase fusion receptor is missing the entire tyrosine kinase and C-terminal domains of EphA5. Mice carrying
this allele should be both mutant in EphA5 and have
␤-galactosidase activity in cells that normally express EphA5. Because the EphA5lacZ allele replaces the intracellular domain but
leaves the extracellular domain intact, it is likely that kinaseindependent functions for EphA5 remain intact, as reported for
an analogous lacZ fusion of an EphB class receptor (Henkemeyer
et al., 1996; Birgbauer et al., 2000). EphA5lacZ/lacZ mice reach
adulthood, are fertile, and show no gross morphological defects.
To assess the effects of EphA5 gene disruption on retinocollicular mapping, a focal injection of DiI was made in one retina,
followed by examination of the contralateral midbrain. When
retinal axons near the temporal extreme of wild-type mice were
labeled, a characteristic arborization was seen at the anterior extreme of the SC (Fig. 1 A). When temporal axons of EphA5lacZ/lacZ
mice were labeled, an apparently normal arborization was always
seen, and in approximately half the animals (51% penetrance; 23
of 45 mice), additional more posterior arborizations were seen
(Fig. 1C,D). In some cases (15 of 45), additional dye labeling
localized to the extreme SC–inferior colliculas (IC) border (Figs.
1 D, 2 E).
When axons near the nasal extreme of the retina were labeled,
wild-type mice always showed a single arborization near the posterior end of the SC (Fig. 1 F). EphA5lacZ/lacZ mice showed an
apparently normal arborization near the posterior end of the SC,
and in approximately half the mutants there were additional arborizations in more anterior locations (42% penetrance; 6 of 14
mice) (Figs. 1 H, 1 I). No comparable phenotypes of either temporal or nasal axons could be detected in EphA5lacZ/⫹ heterozygotes (0 of 20 mice) (Figs. 1 B, 1G), although we cannot rule out
more subtle defects that would not be seen by the methods used
here.
Up to four distinct arborizations were seen in the SC of individual mutants, with the average number of arborizations being
2.0 ⫾ 1.17 (mean ⫾ SD) for nasal labelings and 1.6 ⫾ 0.77 for
temporal labelings. The ectopic terminations generally extended
within the same A–P half of the SC as in wild-type mice and did
not appear to be targeted to any specific ectopic position. In a few
cases (three of the six EphA5lacZ/lacZ mice that had ectopic nasal
axon arborizations), the ectopic arborizations seemed to have
slight dorsoventral errors, suggesting that EphA5 may also play
some role in mapping this axis (Fig. 1 H).
DiI injections were made approximately at the midpoint of
the nasotemporal axis in other mutant animals. Such labelings
revealed multiple arborizations in most cases (75% penetrance; 8
of 12 animals) (Fig. 2 A). Although it is not possible to be certain
which, if any, of these multiple arborizations were “normal,”
there was always a particularly bright spot at the topographically
expected position and additional fainter spots displaced in anterior or posterior directions (Fig. 2 A).
Because labelings were analyzed over a fairly broad range of
ages, it was of interest to see whether the time of labeling had an
effect on the results. Grouping all EphA5lacZ/lacZ labelings by age,
mapping abnormalities were seen in 27 of 52 mice at P12–P14
and 10 of 19 mice at P15–P20, similar in each case ( p ⫽ 0.97;
Mann–Whitney U test). The results, thus, provided no indication
that the phenotype is attributable to a developmental delay or is
corrected within this period.
To test whether retinal axons fill their target areas, we injected
fluoresceinated cholera toxin subunit into the eye to label ganglion cells throughout the retina. The results show that in
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Figure 1. Mapping abnormalities in the SC of EphA5lacZ/lacZ mutant mice. Retinal axons
labeled by focal DiI injection were visualized at P14 by florescence microscopy of SC whole
mounts. The brackets indicate SC; anterior is at the top. A–D, Temporal injections. Temporal
retinal injections in wild-type ( A) or EphA5lacZ/⫹ heterozygous ( B) mice show an arborization in
the anterior portion of the SC. Similar injections in EphA5lacZ/lacZ mutants (C, D) show ectopic
arborizations posterior to the normal location. F–I, Nasal injections. Nasal retinal injections in
wild-type ( F) or EphA5lacZ/⫹ heterozygous ( G) mice show arborizations at the posterior extreme of the SC. EphA5lacZ/lacZ mutants show ectopic arborizations anterior to the normal site. In
addition to ectopic spots, all labelings in the EphA5lacZ/lacZ mutants showed a prominent arborization at the normal location. The arrows indicate ectopic arborizations. E, J, Temporal or
nasal retinal quadrants, respectively, showing typical labeling sites. Axons exit the retina at the
optic disc (OD).

EphA5lacZ/lacZ mice the RGCs still reach and fill the entire SC (Fig.
2C,D). Parasagittal sections across the midbrain in mutant animals reveal that the ectopic arbors seem morphologically similar
to normal ones and that EphA5 is not essential for targeting to the
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Figure 3. Patterning of the retina and SC in EphA5lacZ/lacZ mice. A–C, Horizontal sections
through the P0 eye from wild-type ( A) or EphA5lacZ/lacZ (B, C) mice. A, EphA5 receptor RNA is in
a temporal⬎nasal gradient in wild-type retina. B, EphA5 detected by ␤-galactosidase staining
in EphA5lacZ/lacZ remains in a temporal⬎nasal gradient. C, EphA6 receptor RNA is also in a
temporal⬎nasal gradient in EphA5lacZ/lacZ mutant retinas. D, E, Midbrains in EphA5lacZ/lacZ mice
are patterned normally. D, Whole-mount ␤-galactosidase staining of EphA5lacZ/lacZ mutant
midbrain is in an anterior⬎posterior gradient. E, Ligand expression detected by binding of an
EphA3-AP probe remains in a posterior⬎anterior gradient in EphA5lacZ/lacZ mutants. N, Nasal; T,
temporal; GCL, ganglion cell layer. The brackets indicate the SC and IC regions of the midbrain.
Figure 2. Analysis of the visual projections in EphA5lacZ/lacZ mice. A, Axons labeled approximately in the middle of the nasal–temporal axis by focal DiI injections in ventral retina were
visualized at P14 by fluorescence microscopy of SC. EphA5lacZ/lacZ mutants show ectopic arborizations both anterior and posterior to the expected location. The arrows indicate likely
ectopic arborizations. A bracket indicates the anterior and posterior boundaries of the SC. B,
Parasagittal section through the SC shown in A. Ectopic arborizations branch to the correct layer
of the SC. C, D, Eye fill with fluoresceinated cholera toxin ␤ subunit to anterogradely label
projections throughout the retina. Labeled axons fill the SC in both wild-type and EphA5lacZ/lacZ
mutant animals in C and D, respectively. E, Horizontal section through the midbrain of an
EphA5lacZ/lacZ mouse given an injection in the temporal retina. Axons can be seen at the extreme
SC–IC border (arrow indicates path of axons along the lateral extreme of the SC). F, Wholemount view of P3 mouse SC, after eye fill with DiI at P2. The arrow indicates axons passing
through the SC to the posterior extreme of the IC.

correct layer of the SC (Fig. 2 B). In addition to effects within the
SC map, the EphA5lacZ/lacZ mutation causes an abnormal overshooting of retinal axons into the IC at early developmental stages
(Fig. 2 F), apparently similar to the overshooting previously
noted in ephrin-A5 ⫺/⫺ mutants (Frisén et al., 1998).
In principle, mapping abnormalities could result not from a
loss of EphA5 function, but only from a dominant-negative effect
of the EphA5lacZ allele on a different Eph receptor, but this seems
unlikely, especially because no dominant phenotype was observed in EphA5lacZ/⫹ heterozygotes. It is also possible that the
phenotype could be explained by a role for EphA5 in establishing
a tangential pattern of the retina or SC, rather than a direct role in
axon guidance. To address this, we tested the EphA5lacZ/lacZ mice
for expression of ␤-galactosidase as well as regional markers.
EphA5 is expressed in a temporal⬎nasal gradient in the RGC
layer of the mouse embryo (Feldheim et al., 1998) (Fig. 3A).
Sections derived from EphA5lacZ/lacZ mice and stained for
␤-galactosidase activity show a temporal⬎nasal gradient of ex-

pression in the RGC layer of the retina (Fig. 3B), which is similar
to that seen in EphA5lacZ/⫹ heterozygous mice (data not shown).
EphA6 is also known to be in a temporal⬎nasal gradient across
the mouse retina (Feldheim et al., 2000). This gradient was still
present in EphA5lacZ/lacZ mutants (Fig. 3C). In the mouse SC,
ephrin-A2 and ephrin-A5 are expressed in a posterior⬎anterior
gradient, and this gradient can be detected with an EphA3-AP
fusion protein (Cheng et al., 1995). We find that this binding
gradient is still present in the EphA5lacZ/lacZ mutant (Fig. 3E).
Although the possibility of a subtle patterning difference cannot
be eliminated, there did not appear to be any major change in the
graded patterning of cell fates in the retina or tectum that could
account for the mapping phenotype.
Effect of EphA5 mutation on response to repellent activity
in vitro
In addition to the prominent EphA5 expression in the RGC layer
of the retina, we found EphA5-␤-galactosidase expression in the
SC of EphA5lacZ/lacZ mice in an anterior⬎posterior gradient (Fig.
3D). This expression is consistent with previous studies showing
EphA receptors localized in this manner in the SC (Ciossek et al.,
1995; Flenniken et al., 1996; Park et al., 1997; Connor et al., 1998;
Marin et al., 2001). Therefore, tests for mapping abnormalities in
vivo in the mutant mice do not resolve whether EphA5 acts in the
SC, the retina, or both. To examine this, we performed in vitro
stripe assays in a mix-and-match format in which either the retinal explants or the SC membranes were taken from wild-type or
mutant mice.
In the first series of experiments, we tested whether EphA5 is
required for the detection of repellent activity in the SC. It has
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previously been shown in chick (Walter et al., 1987b), mouse
(Godement and Bonhoeffer, 1989), and rat (Simon and O’Leary,
1992; Roskies and O’Leary, 1994) that membranes from posterior
tectum/SC will repel retinal axons or inhibit their branching in a
topographically specific manner and that ephrin-A2 and
ephrin-A5 are sufficient for this activity in vitro (Nakamoto et al.,
1996; Monschau et al., 1997). EphA receptors are predicted to be
involved in the response, based on several lines of evidence, including retinal expression gradients (Cheng et al., 1995; Feldheim
et al., 1998, 2000; Brown et al., 2000), the addition of soluble
ligand or receptor fusion proteins in vitro (Ciossek et al., 1998),
antibody or dominant-negative inhibition in vitro of chick
EphA4, a receptor that is not graded but seems to be involved in
retinal responses (Walkenhorst et al., 2000), and ectopic expression of EphA3 in mouse retina (Brown et al., 2000). To test by a
genetic loss-of-function approach the requirement of EphA5 in
the retinal axon response, we performed stripe assays comparing
mutant or wild-type retinal axons growing on membranes from
wild-type SC (Fig. 4). Wild-type mouse posterior SC membranes
repelled temporal explants derived from wild-type or
EphA5lacZ/⫹ heterozygous retinas (Fig. 4 A, C,E). However, when
temporal explants were derived from EphA5lacZ/lacZ mutant mice,
they showed a much reduced responsiveness to posteriorly derived SC membranes compared with wild type temporal axons
( p ⬍ 0.001) (Fig. 4 D, E). The responsiveness of the mutant temporal axons to recombinant ephrin-A2 or ephrin-A5 was also
reduced (data not shown). Nasal axons showed no obvious
change in the EphA5lacZ/lacZ mutant, remaining unresponsive to
SC membranes (Fig. 4 E).
We also tested by genetic loss-of-function whether EphA5 has
a role in the SC. To do this, we performed stripe assays with
wild-type retinal axons growing on membranes from wild-type
or mutant SC. In both cases, posterior-derived membranes repelled temporal, but not nasal, axons, similar to the result with
wild-type-derived membranes (Fig. 4 B, E). We cannot rule out a
subtle change in the guidance properties of SC membranes, and
in principal, it might be expected that removal of receptor might
unmask some ephrin activity in the SC. However, because the
EphA5lacZ allele only removes the intracellular portion of the molecule, it seems likely that any masking of ephrin activity in the SC
would remain in the mutants. Within the limits of our analysis,
the differential repellent properties of posterior versus anterior
SC appeared intact in the mutant.
Ectopic expression of cytoplasmically truncated EphA3
in chick
As an independent test of receptor function in topographic mapping, we used a misexpression approach with the RCAS retroviral
vector in chick retina (Fekete and Cepko, 1993). The receptor
patterns in chick and mouse differ, and unlike in mouse where
EphA3 expression has not been detected in RGCs, in chick the
EphA3 receptor is in a prominent nasotemporal gradient across
the RGC layer and was proposed to act as a topographically specific label (Cheng et al., 1995). We previously found that viral
overexpression of ephrin-A2 patches in chick tectum causes
avoidance by temporal retinal axons (Nakamoto et al., 1996).
Here, we tested the effect of a truncated EphA3 receptor, using
the virus RCAS-EphA3⌬C. This vector encodes an EphA3 receptor lacking most of the intracellular region, including the tyrosine
kinase domain (Nishida et al., 2002). Such truncated receptors
are expected to act in a dominant-negative manner by heterodimerizing with endogenous receptors or by sequestering ligand, and although the specific mechanism was not tested here,
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Figure 4. Mix-and-match stripe assays of retina and SC from EphA5lacZ/lacZ or wild-type
mice. A, B, Repellent activity in the SC of EphA5lacZ/lacZ mice. Temporal axons from wild-type
mice were tested with alternating anterior and posterior stripes of SC membranes from wildtype ( A) or EphA5lacZ/lacZ ( B) mice. C, D, Loss of responsiveness of temporal axons from
EphA5lacZ/⫹ and EphA5lacZ/lacZ mutant mice. Temporal axons from EphA5lacZ/⫹ ( C) or EphA5lacZ/
lacZ ( D) mice were grown on alternating anterior and posterior SC stripes from wild-type mice. E,
Results of mix-and-match stripe assays using retina or SC from wild-type (WT) or EphA5lacZ/lacZ
mice. Axon preference for anterior SC lanes was scored on a scale of 0 (no preference) to 4
(strong preference). The bars show means ⫾ SEM. N, Nasal; T, temporal. Axons are shown in
green; red fluorescent microspheres mark posterior SC stripes.

this approach has been used widely for Eph receptors and other
receptor tyrosine kinases (van der Geer et al., 1994; Xu et al.,
1995; Lackmann et al., 1998; Holmberg et al., 2000).
A virus was injected into the optic cup of chick embryos at E2
in ovo. Because the virus was injected into the optic cup, which
protrudes laterally from the main neural tube, it was relatively
easy to restrict the virus infection in the retina. This was confirmed by incorporating dye with the injected virus solution, and,
in addition, several embryos were tested by in situ staining with
an EphA3-AP probe, confirming that ectopic expression could
not be detected in the tectum or elsewhere outside the retina. As
judged by in situ hybridization for EphA3 RNA sequences, much
of the retinal surface was infected, with the extent varying in
different embryos. The distribution was patchy, and within these
patches EphA3 RNA levels were higher than the endogenous ex-
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abnormal locations, as well as a termination zone at the expected location (Fig.
5C). The ectopic arborizations were more
posterior than the normal location, with
no indication of obvious dorsoventral defects. In most cases, the ectopic arbors
were located in the same two-thirds of the
tectum as the normal termination site and
never reached all the way to the posterior
end. Our results appear consistent with the
idea that the mistargeted temporal axons
are the same ones that express EphA3⌬C,
although attempts to show this directly
were unsuccessful using several different
Figure 5. Cytoplasmically truncated EphA3 leads to mapping and guidance errors of temporal retinal axons. A, Pattern of marker strategies in this chick retroviral
retroviral vector infection in chick retina. Whole-mount in situ hybridization with an EphA3 RNA probe to detect EphA3⌬C on chick expression system (data not shown). We
retinas after injection of virus into the optic cup at E2. This is an example with a relatively extensive expression of exogenous EphA3 found no obvious abnormalities of nasal
RNA; in other cases, patches were sparser. B, C, Truncated EphA3 leads to mapping and guidance errors of temporal retinal axons. axons under the same conditions (0 of 5
Temporal retinal axons were labeled by DiI and visualized by fluorescence microscopy as whole-mount chick tectum. B, Wild-type embryos; p ⬍ 0.05). However, an undertemporal axons map to the anterior tectum. C, Temporal axons infected with RCAS-EphA3⌬C project to abnormally posterior shooting phenotype of nasal axons might
locations in the tectum. Arrows indicate ectopic arbors. Insets show schematic view of labeled axons with respect to the tectum. be harder to detect than the overshooting
phenotype of temporal axons, and we cannot rule out the possibility of a nasal axon phenotype that was not
detected here.
We also tested the effects of these viral constructs on axon
guidance, using an in vitro stripe assay (Fig. 6). When retinal
axons were traced after being infected with the RCAS-EphA3⌬C
virus, temporal axons showed significantly reduced responsiveness to posterior tectal membranes (temporal axons from
EphA3⌬C infected retina: mean score, 1.16; SD, 1.12; SEM, 0.26;
n ⫽ 19; control temporal axons: mean score, 2.88; SD, 0.64; SEM,
0.23; n ⫽ 8; p ⬍ 0.001) (Fig. 6). These results are consistent with
the effect of the RCAS-EphA3⌬C virus on temporal mapping in
vivo and with the idea of a repellent forward signaling function
for EphA3 and possibly other EphA receptors in retinal axons.

Discussion

Figure 6. Stripe assay of axons from RCAS-EphA3⌬C-infected or normal chick retina. Explants from temporal retina were placed on membrane carpets consisting of alternating stripes
of membranes derived from anterior or posterior tectum. Preference for anterior lanes was
scored blind on a scale of 0 (no detectable preference) to 4 (strong preference). A, Temporal
axons from normal chick retina prefer anterior stripes to posterior stripes (score, 4). B–D, Temporal axons from chick retina infected with RCAS-EphA3⌬C virus tended to show a reduced
preference. The results were somewhat variable, sometimes even within a single explant, perhaps reflecting patchy virus infection. B shows an extreme example with axons growing similarly over both anterior and posterior stripes (score, 0), whereas C (score, 2) and D (score, 3)
show intermediate examples. Axons are shown in green; blue fluorescent microspheres mark
posterior tectal stripes, and smaller microspheres were used in C and D.

pression, as seen on whole mounts (Fig. 5A) or sections (data not
shown). At E16, DiI was focally injected into nasal or temporal
extremes of the retina, and the projections were visualized as
whole mounts at E18.
In embryos injected with truncated EphA3 receptors, when
retinas were labeled in the temporal extreme, we found clear
mapping errors. In most cases (9 of 15 embryos; different from
wild type with p ⬍ 0.001), there were additional terminations in

Eph receptors and their ligands, the ephrins, are thought to act as
positional labels for the establishment of topographic maps (Drescher et al., 1997; Flanagan and Vanderhaeghen, 1998; O’Leary
and Wilkinson, 1999; Feldheim et al., 2000). Much of this analysis
has come from the study of the projection of visual information
from the retina to the tectum, or its mammalian equivalent the
SC. The existing loss-of-function analysis has so far focused
mainly on the role of ephrins in this projection. Here, loss-offunction approaches are used to characterize the role of EphA
receptors in retinotectal mapping in both mouse and chick.
Loss-of-function shows endogenous EphA receptors are
required for proper topographic guidance in vitro and in vivo
The expression of EphA receptors in temporal⬎nasal gradients,
EphA3 in chick (Cheng et al., 1995) and EphA5 and EphA6 in
mouse (Feldheim et al., 1998, 2000), initially led to the idea that
these graded EphA receptors may act as topographically specific
labels in the retina. Here, we demonstrate that gene targeting of
the EphA5 tyrosine kinase domain in mouse results in topographically specific mapping errors in both temporal and nasal
axons showing by loss-of-function that EphA receptor action is
required for proper map development in vivo. We also demonstrate that retinal axons derived from the EphA5 gene-targeted
mice lose much of their responsiveness to posterior SC membranes in vitro, demonstrating a requirement for forward EphA
receptor signaling in topographically specific axon guidance. Our
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loss-of-function experiments in chick support a similar conclusion. A truncated version of EphA3, which is presumed to heterodimerize with and inactivate endogenous receptors (van der
Geer et al., 1994; Xu et al., 1995; Lackmann et al., 1998; Holmberg
et al., 2000), was retrovirally expressed in chick retina. Temporal
retinal axons showed a reduction in responsiveness to posterior
tectal membranes in vitro and mapped to abnormally posterior
tectal positions in vivo. Although it may seem somewhat surprising that the topographic receptors used in mouse versus chick
would be different, because one would generally expect orthologous molecules to have a conserved function, rapid evolutionary
shifts from one ephrin to another have been seen in other systems
(Wang and Anderson, 1997). In the retinotectal system, the analysis here provides functional support for the idea that, although
the combination of EphA receptors expressed in chick and mouse
retina differs, retinal EphA receptors including EphA5 in mouse
and EphA3 in chick appear to have similar functions in mapping.
Comparison of EphA5 gene-targeting phenotype
ephrin-A phenotypes
The retinocollicular map in the EphA5lacZ/lacZ mutant is similar to
the ephrin-A5 ⫺/⫺ single knock-out mouse in both pattern and
frequency of defects. This phenotype is not as penetrant or severe
as the ephrin-A2 ⫺/⫺; ephrin-A5 ⫺/⫺ double knock-out mouse.
The incomplete loss of map topography in ephrin-A5 ⫺/⫺ mice
can be explained by partial redundancy with ephrin-A2, and possibly other guidance molecules such as RGM. Likewise, the partially penetrant phenotype of the EphA5 mutant could be explained by partial redundancy in the retina, because an
overlapping temporal⬎nasal gradient of EphA6 is present in the
RGC layer and is maintained in the EphA5lacZ/lacZ mutant.
The close similarities between the EphA5lacZ/lacZ phenotype
and the ephrin-A5 ⫺/⫺ single knock-out phenotype are intriguing. Just as observed here in EphA5lacZ/lacZ mice, temporal axon
labelings in ephrin-A5 ⫺/⫺ mice revealed arborizations at the correct location, as well as somewhat more posterior ectopic arborizations in about half the mice and additional arborizations at
the SC–IC boundary (Frisén et al., 1998), whereas nasal axon labelings revealed arborizations at the correct location and more anterior
ectopic arborizations in about half the mice (Feldheim et al., 2000).
Furthermore, in both the ephrin-A5 ⫺/⫺and EphA5lacZ/lacZ mice, retinal axons overshoot abnormally into the IC at early stages of mapping (Frisén et al., 1998). In contrast, ephrin-A2 ⫺/⫺ mutants showed
no indication of overshooting into the IC, or arborizations at the
SC–IC boundary, or a nasal axon phenotype, or, in other words,
none of the phenotypes seen in posterior midbrain in which ephrin-A5 expression is especially prominent (Feldheim et al., 2000).
Although binding analyses have suggested a high degree of promiscuity in Eph– ephrin interactions, the close similarity of the EphA5
and ephrin-A5 mutant phenotypes provides genetic evidence that
there could be a preferential functional relationship of this particular
ligand–receptor pair in vivo.
Tests of a model for mapping involving repulsion
and competition
Our ectopic expression studies in chick appear consistent with
the idea that EphA3 can transduce a repellent signal. When
EphA3⌬C was expressed in a subset of RGCs, temporal axons,
which normally have high receptor levels, mapped to abnormally
posterior positions in vivo and showed reduced responsiveness to
tectal repellents in vitro. Likewise, in EphA5lacZ/lacZ mutant mice,
temporal axons showed abnormally posterior mapping and lost

Feldheim et al. • EphA Receptors in Retinotopic Mapping

much of their responsiveness to repulsion by posterior SC membranes in vitro.
However, this repellent model does not by itself account for
the behavior of extreme nasal axons in the EphA5lacZ/lacZ mutant,
because their terminations shift in the opposite, anterior direction in the SC. These considerations appear analogous to our
previous studies in ephrin-A2 ⫺/⫺; ephrin-A5 ⫺/⫺ knock-out
mice, in which nasal and temporal axons showed quantitatively
similar, but opposite, shifts (Feldheim et al., 2000). Two different
models to account for nasal axon mapping behavior have been
proposed: a model involving masking of receptor by ligands in
the retina (Hornberger et al., 1999; McLaughlin and O’Leary,
1999; Feldheim et al., 2000; Wilkinson, 2000) or a model based on
axon competition (Brown et al., 2000; Feldheim et al., 2000).
Incorporating the new data from the EphA5lacZ/lacZ mice helps in
distinguishing these two models.
Supporting a receptor-masking model, we showed previously
by genetic loss-of-function in mice that nasal axons from ephrinA2 ⫺/⫺; ephrin-A5 ⫺/⫺ mutants have a strongly elevated response
to posterior SC repellent activity in vitro (Feldheim et al., 2000).
These results seem very consistent with previous studies in chick
showing that retinal overexpression of ephrin-A5 causes axons to
map more posteriorly and that treatment of the retina with
phosphatidylinositol-specific phospholipase makes nasal axons
more sensitive to ephrins in vitro (Hornberger et al., 1999). Those
studies suggest ephrin-As in nasal retina mask retinal EphA receptors. Therefore, removal of the mask could explain why nasal
axons shift anteriorly in the ephrin knock-out mutants (Hornberger et al., 1999; McLaughlin and O’Leary, 1999; Feldheim et
al., 2000; Wilkinson, 2000).
However, it does not seem that this masking model can account
for the comparable nasal axon shift seen here in EphA5lacZ/lacZ mice.
In these animals, removal of the EphA5 tyrosine kinase domain
should not decrease masking of receptors, and confirming this expectation, we saw no increase in the repellent responsiveness of nasal
axons in vitro. In addition, the EphA5lacZ/lacZ mutation is not expected to alter repellent activity in the SC, and consistent with this,
we saw no change of receptor binding activity in the SC and no
increase of posterior-derived in vitro repellent activity. We would
like to emphasize that masking very likely contributes to the normal
process of mapping, based on previous evidence (Hornberger et al.,
1999; Feldheim et al., 2000). However, in view of the results here, it
does not seem likely that the masking model can fully explain the
anterior shift of nasal axons in the mutants, so an alternative explanation seems to be needed.
One model that may fit all our gain- and loss-of-function
results involves a repellent gradient of ephrin, in combination
with axon–axon competition for space in the target (Brown et al.,
2000; Feldheim et al., 2000). Briefly, a repulsion/competition
model could account for normal mapping as follows. Temporal
axons have high EphA receptor and are strongly repelled by posterior ephrins, so that they terminate in the anterior SC. Nasal
axons have low levels of receptor, so they can terminate in posterior SC. Nasal axons have to compete with temporal axons in the
anterior SC, so they prefer to avoid this competition and terminate only in the posterior SC.
Our results here do not seem easy to explain without an
element of competition, and appear to be consistent with a
repulsion– competition model. (1) In mouse, the EphA5lacZ/
lacZ mutation shifts temporal axons posteriorly and nasal axons
anteriorly. According to the competition model, axons from temporal (or central) retina are now able to grow more easily in
posterior SC. Nasal axons, therefore, face increased competition
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here, lose their strong preference for this region, and spread out
into more anterior regions. (2) In chick, the EphA3⌬C construct
causes temporal axons to map more posteriorly, which can be
explained by the infected RGCs having a lower level of repellent
receptor relative to their normal neighbors. The lack of an obvious nasal axon phenotype might be explained by the patchy expression in the chick experiments, so that the competition faced
by nasal axons may not be strongly affected, although it is also
possible that nasal axons may have had an undershooting phenotype that would be difficult to detect by the methods used here.
(3) Axons in the EphA and ephrin-A mutants are not respecified
to a specific ectopic position. Instead, there are multiple arborizations, including both normal and abnormal regions. According
to the competition model, when topographically specific labels
no longer adequately bias the competition, axons are expected to
arborize over an abnormally broad region, rather than being retargeted to a specific ectopic location. The lack of an obvious
phenotype in the EphA5lacZ/⫹ heterozygote could be explained if
enough of a gradient remains to adequately bias competition, as
suggested for ephrin-A mice which show a phenotype in the ephrin-A2 ⫹/⫺; ephrin-A5 ⫹/⫺ double heterozygote but no obvious
phenotype in the single heterozygotes (Feldheim et al., 2000). (4)
In the EphA5 and ephrin-A mutants, retinal axons fill the entire
SC. Likewise, axons from both nasal and temporal extremes of
the retina still form termination zones within the target. These
results are difficult to reconcile with mapping models that involve
a strict matching of values in the projecting and target field
(which would predict that the mutants should have unmatched
areas) but can be explained by incorporating competition.
An important feature of axon competition is that it can provide a mechanism to ensure that axons fill the available space.
This may be a major advantage biologically, because it can provide a mechanism to ensure that, even if there are variations in the
concentrations of the topographically specific labels during development or evolution, the projecting and target areas will still
match up. These principles of mapping in the retinotectal system
probably apply to other topographic projections and may lend to
topographic mapping a robust quality that is increasingly emerging as an important feature in molecular control of many biological systems.
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